Periodontitis Completed Phase 3 Trials for Trafermin (DB06244)

Also known as: PERIODONTITIS / Chronic pericoronitis

IndicationStatusPhase
DBCOND0010286 (Periodontitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01015404A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)Treatment
NCT00734708Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)Treatment